Mitochondria at the heart of cardiovascular protection: P66shc-friend or foe?

European Heart Journal

Volumn 36, Issue 8, 2015, Pages 469-471

  Heusch, Gerd ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADAPTOR PROTEIN; P66 SHC PROTEIN; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; UNCLASSIFIED DRUG; PROTEIN SHC;

CARDIOVASCULAR SYSTEM; CELL SURVIVAL; CELLULAR STRESS SIGNAL; CORONARY ARTERY OCCLUSION; CYTOSOL; EDITORIAL; ENDOTHELIAL DYSFUNCTION; GENE SILENCING; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; ANIMAL; GENE DELETION; GENETICS; MALE;

ANIMALS; GENE DELETION; MALE; MYOCARDIAL REPERFUSION INJURY; SHC SIGNALING ADAPTOR PROTEINS;

EID: 84924546245     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu409     Document Type: Editorial

References (24)

1. Heusch G, Boengler K, Schulz R. Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection. Basic Res Cardiol 2010;105: 151-154.
2. Carraro M, Giorgio V, Sileikyte J, Sartori G, Forte M, Lippe G, Zoratti M, Szabo I, Bernardi P. Channel formation by yeast F-ATP synthase and the role of dimerization in the mitochondrial permeability transition. J Biol Chem 2014;289:15980-15985.
3. Alavian KN, Beutner G, Lazrove E, Sacchetti S, Park HA, Licznerski P, Li H, Nabili P, Hockensmith K, Graham M, Porter GA Jr, Jonas EA. An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc Natl Acad Sci USA 2014;111:10580-10585.
4. Heusch G, Boengler K, Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 2008;118:1915-1919.
5. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013;381:166-175.
6. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia- reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 2004;61:448-460.
7. Lecour S. Multiple protective pathways against reperfusion injury: a SAFE path without Aktion?. J Mol Cell Cardiol 2009;46:607-609.
8. Pain T, Yang X-M, Critz SD, Yue Y, Nakano A, Liu GS, Heusch G, Cohen MV, Downey JM. Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Circ Res 2000;87:460-466.
9. Heinzel FR, Luo Y, Li X, Boengler K, Buechert A, Garciåa-Dorado D, Di Lisa F, Schulz R, Heusch G. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res 2005;97:583-6.
10. Boengler K, Ungefug E, Heusch G, Leybaert L, Schulz R. Connexin 43 impacts on mitochondrial potassium uptake. Front Pharmacol 2013;4:73.
11. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/ reperfusion. Basic Res Cardiol 2010;105:771-785.
12. Boengler K, Ungefug E, Heusch G, Schulz R. The STAT3 inhibitor stattic impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formation. Curr Pharm Des 2013;19:6890-6895.
13. Heusch G, Musiolik J, Gedik N, Skyschally A. Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 2011;109:1302-1308.
14. GiorgioM, Migliaccio E, Orsini F, Paolucci D, MoroniM, Contursi C, PellicciaG, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, PelicciPG. Electron transfer between cytochrome c and p66(Shc) generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005;122:221-233.
15. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, Pelicci PG. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999;402:309-313.
16. GiorgioM, Berry A, Berniakovich I, Poletaeva I, Trinei M, Stendardo M, Hagopian K, Ramsey JJ, Cortopassi G, Migliaccio E, Notzli S, Amrein I, LippHP, Cirulli F, Pelicci PG. The p66Shc knocked out mice are short lived under natural condition. Aging Cell 2012;11:162-168.
17. Cosentino F, Francia P, Camici GG, Pelicci PG, Luscher TF, Volpe M. Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. Arterioscler Thromb Vasc Biol 2008;28:622-628.
18. Berry A, Carnevale D, Giorgio M, Pelicci PG, de Kloet ER, Alleva E, Minghetti L, Cirulli F. Greater resistance to inflammation at adulthood could contribute to extended life span of p66(Shc-/-) mice. Exp Gerontol 2010;45:343-350.
19. Paneni F, Mocharla P, Akhmedov A, Costantino S, Osto E, Volpe M, Luscher TF, Cosentino F. Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes. Circ Res 2012;111:278-289.
20. Camici GG, Schiavoni M, Francia P, Bachschmid M, Martin-Padura I, Hersberger M, Tanner FC, Pelicci P, Volpe M, Anversa P, Luscher TF, Cosentino F. Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci USA 2007;104:5217-5222.
21. Di Lisa F, Kaludercic N, Carpi A, Menabo R, Giorgio M. Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66(Shc) and monoamine oxidase. Basic Res Cardiol 2009;104:131-139.
22. Carpi A, Menabo R, Kaludercic N, Pelicci P, Di LF, Giorgio M. The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury. Biochim Biophys Acta 2009;1787: 774-780.
23. Spescha RD, Shi Y, Wegener S, Keller S, Weber B, Wyss MM, Lauinger N, Tabatabai G, Paneni F, Cosentino F, Hock C, Weller M, Nitsch RM, Luscher TF, Camici GG. Deletion of the ageing gene p66Shc reduces early stroke size following ischaemia/reperfusion brain injury. Eur Heart J 2013;34:96-103.
24. Akhmedov A, Montecucco F, Braunersreuther V, Camici GG, Jacob P, Reiner MF, Glanzmann M, Burger F, Paneni F, Galan K, Vuilleumier N, Belin A, Valleåe JP, Mach F, Lüscher TF. Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways. Eur Heart J 2015;36:516-526.